-2.40 | -2.71%
| Price and Volume | |
|---|---|
| Recent Price | 88.51 |
| 52 Week High | 108.79 |
| 52 Week Low | 85.99 |
| Avg. Daily Vol. (Mil) | 0.52 |
| Beta (3 year) | 0.61 |
| Share Related Items | |
| Mkt Cap (Mil) | 16,596.58 |
| Shares Out (Mil) | 187.51 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 0.90 |
| Annual Dividend | 0.76 |
| Payout Ratio | 10.00 |
| Financial Strength | |
| Quick Ratio | 1.20 |
| Current Ratio | 1.80 |
| LT Debt/ Equity | 0.31 |
| Total Debt / Equity | 0.31 |
| Valuation Ratios | |
| Price Earnings | 19.00 |
| Price/Sales | 3.72 |
| Price/Book | 4.71 |
| Price/Cash Flow | 13.90 |
| Per Share Data | |
| Earnings | 4.66 |
| Sales | 23.80 |
| Book Value | 18.78 |
| Cash Flow | 6.38 |
| Business Summary | |
|---|---|
| Shire PLC is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. The principal activity of the company is the research and development, manufacture, sale and distribution of pharmaceutical products. | |
| General Information | |
| 5 Riverwalk
Citywest Business Campus Dublin, 24 |
|
| www.shire.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 5251 | |
| CEO: Angus Charles Russell | |
| Short Interest | |
| Current Month (Mil) | 0.78 |
| Previous Month (Mil) | 0.73 |
| Short Interest Ratio (Days) | 1.60 |
| Management Effectiveness | |
| Return on Equity | 25.30 |
| Return on Assets | 13.30 |
| Return on Investments | 19.30 |
| Profitability | |
| Gross Margin | 92.90 |
| EBIT Margin | 26.00 |
| Profit Margin | 20.00 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,419.86 | 1,313.32 | 2,837.36 | 16.25 |
Oil *
103.09
|
|
DOWN
160.83 |
DOWN
19.10 |
DOWN
33.63 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.28%
|
-1.43%
|
-1.17%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet